Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLNCF) Amortizatization of Intangibles (2020 - 2025)

Historic Amortizatization of Intangibles for Silence Therapeutics (SLNCF) over the last 6 years, with Q3 2025 value amounting to $75000.0.

  • Silence Therapeutics' Amortizatization of Intangibles rose 62154.22% to $75000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $271000.0, marking a year-over-year increase of 17959.83%. This contributed to the annual value of $257000.0 for FY2024, which is 198.41% up from last year.
  • According to the latest figures from Q3 2025, Silence Therapeutics' Amortizatization of Intangibles is $75000.0, which was up 62154.22% from $67000.0 recorded in Q2 2025.
  • In the past 5 years, Silence Therapeutics' Amortizatization of Intangibles registered a high of $75000.0 during Q3 2025, and its lowest value of $1178.5 during Q3 2022.
  • Its 5-year average for Amortizatization of Intangibles is $23800.5, with a median of $10782.4 in 2023.
  • Its Amortizatization of Intangibles has fluctuated over the past 5 years, first tumbled by 8053.79% in 2022, then soared by 134936.93% in 2023.
  • Over the past 5 years, Silence Therapeutics' Amortizatization of Intangibles (Quarter) stood at $2696.0 in 2021, then tumbled by 56.29% to $1178.5 in 2022, then skyrocketed by 847.81% to $11170.4 in 2023, then surged by 472.94% to $64000.0 in 2024, then increased by 17.19% to $75000.0 in 2025.
  • Its last three reported values are $75000.0 in Q3 2025, $67000.0 for Q2 2025, and $65000.0 during Q1 2025.